These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11110038)

  • 1. Concentration of vascular endothelial growth factor in the subretinal fluid of retinal detachment.
    Su CY; Chen MT; Wu WS; Wu WC
    J Ocul Pharmacol Ther; 2000 Oct; 16(5):463-9. PubMed ID: 11110038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Concentration of vascular endothelial growth factor within the subretinal space and vitreous fluid in rhegmatogenous retinal detachment].
    Moromizato Y; Hayashi H; Kato H; Ozaki H; Oshima K
    Nippon Ganka Gakkai Zasshi; 1997 Jun; 101(6):498-502. PubMed ID: 9209137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenic isoforms of vascular endothelial growth factor predominate in subretinal fluid of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
    Ricker LJ; Dieudonné SC; Kessels AG; Rennel ES; Berendschot TT; Hendrikse F; Kijlstra A; La Heij EC
    Retina; 2012 Jan; 32(1):54-9. PubMed ID: 21836532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
    Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
    N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased vascular endothelial growth factor level in the subretinal fluid of eye with vasoproliferative retinal tumors.
    Fujiya A; Noda K; Yoshida S; Saito W; Ishida S
    Retin Cases Brief Rep; 2015; 9(2):154-6. PubMed ID: 25521309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity.
    Lashkari K; Hirose T; Yazdany J; McMeel JW; Kazlauskas A; Rahimi N
    Am J Pathol; 2000 Apr; 156(4):1337-44. PubMed ID: 10751359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
    Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.
    Dieudonné SC; La Heij EC; Diederen RM; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
    Ophthalmic Res; 2007; 39(3):148-54. PubMed ID: 17534114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino-acid levels in subretinal and vitreous fluid of patients with retinal detachment.
    Bertram KM; Bula DV; Pulido JS; Shippy SA; Gautam S; Lu MJ; Hatfield RM; Kim JH; Quirk MT; Arroyo JG
    Eye (Lond); 2008 Apr; 22(4):582-9. PubMed ID: 17948040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed absorption of subretinal fluid after scleral buckling procedures: the significance of subretinal precipitates.
    Robertson DM
    Trans Am Ophthalmol Soc; 1978; 76():557-83. PubMed ID: 754382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse levels of pigment epithelium-derived factor and vascular endothelial growth factor in the vitreous of eyes with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
    Ogata N; Nishikawa M; Nishimura T; Mitsuma Y; Matsumura M
    Am J Ophthalmol; 2002 Jun; 133(6):851-2. PubMed ID: 12036691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High TGF-beta2 levels during primary retinal detachment may protect against proliferative vitreoretinopathy.
    Dieudonné SC; La Heij EC; Diederen R; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4113-8. PubMed ID: 15505063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid and vascular endothelial growth factor levels in subretinal fluid in rhegmatogenous retinal detachment.
    Yalcinbayir O; Buyukuysal RL; Gelisken O; Buyukuysal C; Can B
    Mol Vis; 2014; 20():1357-65. PubMed ID: 25352742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
    Stitt AW; Simpson DA; Boocock C; Gardiner TA; Murphy GM; Archer DB
    J Pathol; 1998 Nov; 186(3):306-12. PubMed ID: 10211121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High subretinal fluid procoagulant activity in rhegmatogenous retinal detachment.
    Ricker LJ; Dieri RA; Beckers GJ; Pels E; Liem AT; Hendrikse F; Kijlstra A; Hemker HC; La Heij EC
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5234-9. PubMed ID: 20435588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta(2) increases in subretinal fluid in rhegmatogenous retinal detachment with subretinal strands.
    Hirase K; Sugiyama T; Ikeda T; Sotozono C; Yasuhara T; Koizumi K; Kinoshita S
    Ophthalmologica; 2005; 219(4):222-5. PubMed ID: 16088241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100b protein levels in subretinal fluid in rhegmatogenous retinal detachment.
    Yalcinbayir O; Buyukuysal RL; Akova-Budak B; Gelisken O
    Curr Eye Res; 2012 Nov; 37(11):1030-5. PubMed ID: 22671138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine CXCL-1 expression in the subretinal fluid during rhegmatogenous retinal detachment.
    Symeonidis C; Androudi S; Rotsos T; Moschos MM; Souliou E; Dimitrakos SA; Diza E
    Ocul Immunol Inflamm; 2014 Dec; 22(6):449-53. PubMed ID: 24354433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment.
    Takahashi K; Saishin Y; Saishin Y; Silva RL; Oshima Y; Oshima S; Melia M; Paszkiet B; Zerby D; Kadan MJ; Liau G; Kaleko M; Connelly S; Luo T; Campochiaro PA
    FASEB J; 2003 May; 17(8):896-8. PubMed ID: 12670875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.